Neuberger Berman Group LLC 13D and 13G filings for Haemonetics Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 3:28 pm Sale | 2023-12-31 | 13G | Haemonetics Corporation HAE | Neuberger Berman Group LLC | 3,531,181 6.960% | -342,255 (-8.84%) | Filing |
| 2023-02-10 2:10 pm Sale | 2022-12-31 | 13G | Haemonetics Corporation HAE | Neuberger Berman Group LLC | 3,873,436 7.650% | -3,085 (-0.08%) | Filing |
| 2022-02-14 2:29 pm Purchase | 2021-12-31 | 13G | Haemonetics Corporation HAE | Neuberger Berman Group LLC | 3,876,521 7.590% | 1,043,472 (+36.83%) | Filing |
| 2021-02-11 7:05 pm Purchase | 2020-12-31 | 13G | Haemonetics Corporation HAE | Neuberger Berman Group LLC | 2,833,049 5.570% | 221,133 (+8.47%) | Filing |